Cleveland Diagnostics: Funding, Investors & Team (Oct 2026)
Cleveland Diagnostics is an established company that specializes in developing effective, user-friendly, and cost-effective diagnostic tests for cancer. They use their own technology to study protein biomarkers at a structural level, allowing for more accurate insights into the cellular origins of diseases. By doing so, they aim to improve the accuracy of their tests and their ability to identify the underlying disease process. Cleveland Diagnostics plans to expand its range of non-invasive cancer diagnostic tests beyond prostate cancer to include breast cancer, lung cancer, and certain neurological diseases.
Cleveland Diagnostics has raised $89.4M across 2 funding rounds on record, the most recent an undisclosed round of $14.4M announced in Oct 2025.
That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Cleveland Diagnostics Company Profile and Key Stats
Latest funding round on record: Oct 2025.
Cleveland Diagnostics Funding Rounds
Cleveland Diagnostics raised $75.0M in an undisclosed round announced in Jan 2024.
1.8 years later, an undisclosed round of $14.4M was announced in Oct 2025.
Cleveland Diagnostics Founders and Leadership Team
Contact details for the Cleveland Diagnostics team: 1 of 1 has an email address on file.
Start 14-day free trial →Cleveland Diagnostics Funding Compared to Other Biotechnology Startups
Cleveland Diagnostics' latest round of $14.4M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Cleveland Diagnostics in Biotechnology and Cleveland
Companies Similar to Cleveland Diagnostics
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Cleveland Diagnostics Funding FAQs
What does Cleveland Diagnostics do?
Cleveland Diagnostics is an established company that specializes in developing effective, user-friendly, and cost-effective diagnostic tests for cancer. They use their own technology to study protein biomarkers at a structural level, allowing for more accurate insights into the cellular origins of diseases. By doing so, they aim to improve the accuracy of their tests and their ability to identify the underlying disease process. Cleveland Diagnostics plans to expand its range of non-invasive cancer diagnostic tests beyond prostate cancer to include breast cancer, lung cancer, and certain neurological diseases.
How much funding has Cleveland Diagnostics raised?
Cleveland Diagnostics has raised $89.4M across 2 rounds on record. The most recent is an undisclosed round of $14.4M announced in Oct 2025.
When did Cleveland Diagnostics last raise funding?
Cleveland Diagnostics' most recent funding round on record is an undisclosed round of $14.4M, announced in Oct 2025.
Who founded Cleveland Diagnostics?
FundedIQ lists Arnon Chait (Founder) at Cleveland Diagnostics.
Where is Cleveland Diagnostics headquartered?
Cleveland Diagnostics is based in Cleveland, Ohio, United States.
How many employees does Cleveland Diagnostics have?
Cleveland Diagnostics is in the 51-100 employee band.
How does Cleveland Diagnostics' funding compare to other Biotechnology startups?
Cleveland Diagnostics' latest round of $14.4M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Cleveland Diagnostics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Cleveland Diagnostics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.